JPRN-UMIN000037716Completed未知
Promotion of generic drugs using questionnaire - POGDUQ
Drug Information Center, Chiba Pharmaceutical Association0 sites28 target enrollmentStarted: August 21, 2019Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 28
Study Overview
Brief Summary
o significant differences were observed in the primary endpoint (x2 goodness-of-fit test) and the secondary endpoint (x2 independence test).
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- ot applicable to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patient selects generic drugs Patient visited when the investigator was absent Those have difficulty dealing in Japanese
Investigators
Similar Trials
Completed
Phase 2
Comparative Bioequivalence Study in Adult Patients Suffering From Chronic Myeloid Leukemia & Gastrointestinal Stromal Tumor Under Fed ConditionsChronic Myeloid LeukemiaGastrointestinal Stromal TumorNCT02103322Amneal Pharmaceuticals, LLC48
Completed
Not Applicable
Clinical Performance and Safety Comparison of Stay Safe Link® With Stay Safe® in Patient on CAPD (CAPD-3)Continuous Ambulatory Peritoneal DialysisNCT03177031Penang Hospital, Malaysia472
Completed
Phase 4
Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in BrazilAtrial FibrillationNCT02017197Federal University of São Paulo100
Completed
Phase 4
Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne VulgarisAcne VulgarisNCT00757523Stiefel, a GSK Company382
Unknown
Phase 4
A Trial of Generic Substitution of Antiepileptic DrugsEpilepsyNCT02429596IRCCS National Neurological Institute "C. Mondino" Foundation200
